THE HEADACHE CENTRE LIMITEDActive

Company number 07612445Private limited companyIncorporated 2011

Key figures

£448,609-13.4%
Net assets 2024/25
+14.9%
Average annual growth 2019/20–2024/25
0200 k400 k600 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, THE HEADACHE CENTRE LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0250 k500 k750 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand250,715436,105353,815260,658149,548
Total assets448,044575,669634,811667,501597,775
Total liabilities189,848195,177245,522149,335149,166
Net assets / total equity258,196380,492389,289518,166448,609
Average number of employees22365

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: THE HEADACHE CENTRE LIMITED

Company

THE HEADACHE CENTRE LIMITED is a private limited company registered with Companies House under company number 07612445. It was incorporated on 21 Apr 2011. Its status is active. The registered office is in Staines-upon-thames (TW18). Its nature of business (SIC 2007) is specialists medical practice activities (86220).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Apr 2025); the company files small company accounts (filleted). Net assets were £448,609, down 13.4% on the previous year. Cash at bank and in hand was £149,548. Total assets were £597,775 and total liabilities £149,166. The company had an average of 5 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Jan 2027. The next confirmation statement is due by 8 May 2027.